PRSS50 and breast cancer: However, we found significantly altered p-AKT levels in response to the overexpression or suppression of TSP50 in breast cancer cells, with constant AKT levels, indicating that PI3K/AKT signaling is stimulated by TSP50 (Fig. 7A and B, Fig. S5G and H).